Clinical Trials

1,259 enrolled

Phase 2/3 Active not recruiting

Breast Neoplasms

NCT02135042 2026-03-18

Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

685 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT02491632 2026-03-18

Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

Phase 2/3 Active not recruiting

90 enrolled 13 charts

Fatigue, Neoplasm Metastasis, Neoplasms, Recurrence

NCT02598219 2026-03-18

SENTIRAD

Phase 3 Active not recruiting

262 enrolled

Carcinoma, Endometrioid

NCT02867033 2026-03-18

ALTITUDES

Phase 2/3 Active not recruiting

628 enrolled

Sarcoma

Desmoid Tumors

NCT03021486 2026-03-18

Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer

70 enrolled 20 charts

Delirium, Neoplasm Metastasis, Recurrence

NCT03408665 2026-03-18

STEREOLIVER

280 enrolled

Liver Neoplasms

NCT03663218 2026-03-18

PREPARE SBRT

16 enrolled 9 charts

Prostatic Neoplasms

NCT03795246 2026-03-18

KSF2

132 enrolled

Breast Neoplasms

NCT05055050 2026-03-18

A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630

10 enrolled

Urinary Bladder Neoplasms

NCT05832112 2026-03-18

OTC-RATS

100 enrolled

Thoracic

Lung Neoplasms

NCT06032338 2026-03-18

EXPEDIT

64,000 enrolled

Colorectal Neoplasms

NCT06408597 2026-03-18

Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy

90 enrolled

Urinary Bladder Neoplasms, Prostatic Neoplasms, Renal Insufficiency, Acute Kidney Injury

NCT06810427 2026-03-18

CervImage

18 enrolled

Gynecologic

Uterine Cervical Dysplasia

NCT07480850 2026-03-18

Efficacy and Safety of Glofitamab Combined With GemOxin the Treatment of Refractory Diffuse Large B-Cell Lymphoma

40 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT07480863 2026-03-18

Treatment of BTKi+Hi-CVP Regimen for Previously Untreated MZL

65 enrolled

Lymphoid

Lymphoma, B-Cell, Marginal Zone

NCT02114229 2026-03-17

SJATRT

125 enrolled

Rhabdoid Tumor

NCT02429570 2026-03-17

Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary

CNS

Brain Neoplasms

NCT02482376 2026-03-17

Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer

110 enrolled 18 charts

Breast Neoplasms

NCT04653740 2026-03-17

OMERIC

25 enrolled

Breast Neoplasms

NCT05245006 2026-03-17

PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer

Prostatic Neoplasms

NCT05478512 2026-03-17

VIS

LymphoidOther hematologic neoplasm

78 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05813327 2026-03-17

Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma

6 enrolled

Sarcoma

Sarcoma, Ichthyosis, X-Linked

NCT06141031 2026-03-17

Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

5 enrolled

Pancreatic Neoplasms

NCT06256718 2026-03-17

Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care

203 enrolled

Papillomavirus Infections

NCT06353022 2026-03-17

IFm2022-01

103 enrolled

Multiple Myeloma

NCT07276048 2026-03-17

Community Genetic Navigation Engagement Specialists to Increase Knowledge About Colorectal Cancer Genetics in Hispanic/Latino/a Communities

20 enrolled

Colorectal Neoplasms

NCT07475390 2026-03-17

99mTc-1-thio-D-glucose SPECT/CT Versus 18F-Fluoroethyl-l-tyrosine PET/CT in Brain Tumor Imaging

Phase 3 Active not recruiting

40 enrolled

CNS

Glioma

NCT07477626 2026-03-17

RADVAN

374 enrolled

Prostatic Neoplasms

NCT02068586 2026-03-16

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

210 enrolled

Dermatologic

Uveal Melanoma

NCT03607890 2026-03-16

Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor

38 enrolled

Turcot syndrome, Microsatellite Instability

NCT03742245 2026-03-16

Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer

28 enrolled

Phase 3 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT03842982 2026-03-16

CHIPPI

362 enrolled

Gynecologic

Ovarian Neoplasms

NCT04039230 2026-03-16

Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.

Phase 1/2 Active not recruiting

75 enrolled

Breast Neoplasms

NCT04190446 2026-03-16

A Study to Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer

84 enrolled

Prostatic Neoplasms

NCT04531917 2026-03-16

BCS-PAIN

122 enrolled

Breast Neoplasms, Chronic Pain

NCT05690984 2026-03-16

EMAT

Multiple Myeloma, Neoplasm, Residual

NCT05783596 2026-03-16

Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma

47 enrolled

Lymphoid

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT06133517 2026-03-16

PeRioperative Immunotherapy Combined With Sacituzumab Govitecan in Muscle Invasive blAdder Cancer

70 enrolled

Urothelial Bladder Carcinoma

NCT06286462 2026-03-16

CATSystem

6,600 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06405542 2026-03-16

EX-CIPN

40 enrolled

Peripheral Nervous System Diseases

NCT06652620 2026-03-16

Cola Ingestion for Esophageal Bolus Impaction

50 enrolled

Esophageal Neoplasms

NCT07474168 2026-03-16

T Cell Receptor Gene-Engineered and Dominant Negative TGF-β Receptor T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor

9 enrolled

Tumor-Agnostic

Neoplasms

NCT07475312 2026-03-16

SUPPORT+

633 enrolled

Palliative Care

NCT02515110 2026-03-13

Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer

137 enrolled

Breast Carcinoma In Situ, Breast Neoplasms

NCT02886065 2026-03-13

A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM

19 enrolled

Smoldering Multiple Myeloma, Neoplasms, Plasma Cell

NCT03091257 2026-03-13

A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma

Multiple Myeloma

NCT03360890 2026-03-13

iPRIME

46 enrolled

Head & Neck

Salivary Gland Neoplasms, Thyroid Neoplasms

NCT03749187 2026-03-13

PNOC017